GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Genomtec SA (WAR:GMT) » Definitions » YoY EBITDA Growth

Genomtec (WAR:GMT) YoY EBITDA Growth : 3.82% (As of Mar. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Genomtec YoY EBITDA Growth?

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months. Genomtec's YoY EBITDA Growth for the quarter that ended in Mar. 2024 was 3.82%.

Genomtec's EBITDA per Share for the three months ended in Mar. 2024 was zł-0.15.

Genomtec YoY EBITDA Growth Historical Data

The historical data trend for Genomtec's YoY EBITDA Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Genomtec YoY EBITDA Growth Chart

Genomtec Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
YoY EBITDA Growth
Get a 7-Day Free Trial -26.53 -603.23 38.53 -48.88 46.78

Genomtec Quarterly Data
Dec18 Dec19 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
YoY EBITDA Growth Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -302.56 59.76 -23.81 82.57 3.82

Genomtec YoY EBITDA Growth Calculation

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months.

Genomtec's YoY EBITDA Growth for the fiscal year that ended in Dec. 2023 is calculated as:

YoY EBITDA Growth (A: Dec. 2023 )
=(EBITDA per Share (A: Dec. 2023 )-EBITDA per Share (A: Dec. 2022 ))/ | EBITDA per Share (A: Dec. 2022 ) |
=(-0.637--1.197)/ | -1.197 |
=46.78 %

Genomtec's YoY EBITDA Growth for the quarter that ended in Mar. 2024 is calculated as:

YoY EBITDA Growth (Q: Mar. 2024 )
=(EBITDA per Share (Q: Mar. 2024 )-EBITDA per Share (Q: Mar. 2023 )) / | EBITDA per Share (Q: Mar. 2023 )) |
=(-0.151--0.157)/ | -0.157 |
=3.82 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Genomtec YoY EBITDA Growth Related Terms

Thank you for viewing the detailed overview of Genomtec's YoY EBITDA Growth provided by GuruFocus.com. Please click on the following links to see related term pages.

Genomtec (WAR:GMT) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Genomtec SA (WAR:GMT) » Definitions » YoY EBITDA Growth
Comparable Companies
WAR:SDS WAR:ICE WAR:INM WAR:CMI WAR:NST WAR:MDG WAR:GMZ WAR:ADV WAR:MTN WAR:MSM ABT SYK MDT BSX SZSE:300760 EW DXCM ZBH STE XAMS:PHIA
Traded in Other Exchanges
4VI:Germany
Address
ul. Stab?owicka 147, PORT Building 2, Wroclaw, POL, 54-066
Website
http://www.genomtec.com
Genomtec SA is an innovative technology company which works in the area of ?? molecular diagnostics. It is a manufacturer of mobile molecular analyzers. The device are designed to identify pathogens including viruses, bacteria, and fungi by amplifying and detecting specific DNA and RNA fragments.

Genomtec (WAR:GMT) Headlines

No Headlines